New marker developed by researchers could help identify heart attack patients most at risk.
![New Blood Test Could Help Identify Heart Attack Patients Most at Risk
New Blood Test Could Help Identify Heart Attack Patients Most at Risk](https://images.medindia.net/health-images/1200_1000/multiple-congenital-heart-defects.jpg)
‘New marker provides clues as to why some patients are at higher risk of cardiovascular disease after a heart attack.’
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
Professor Storey, who is also Academic Director and an Honorary Consultant in the Cardiology and Cardiothoracic Surgery Directorate at the Sheffield Teaching Hospitals NHS Foundation Trust, said: "We have made huge strides over the last two decades in improving prognosis following heart attacks but there is still plenty of room for further improvement.![twitter](https://images.medindia.net/icons/news/social/twitter.png)
![facebook](https://images.medindia.net/icons/news/social/facebook.png)
![whatsapp](https://images.medindia.net/icons/news/social/whatsapp.png)
![linkedin](https://images.medindia.net/icons/news/social/linkedin.png)
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
"Our findings provide exciting clues as to why some patients are at higher risk after heart attack and how we might address this with new treatments in the future."
The results, published in the European Heart Journal, showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome.
Professor Storey added: "We now need to press ahead with exploring possibilities for tailoring treatment to an individual's risk following a heart attack and testing whether drugs that improve clot lysis time can reduce this risk."
The Department of Infection, Immunity and Cardiovascular Disease at the University of Sheffield is a world-leading centre for pioneering discoveries which help to fight disease and inform inspiring teaching.
Source-Eurekalert